Billable / Specific Code
ICD-10-CM Z17.32 is the diagnosis code for Human epidermal growth factor receptor 2 negative status. This code falls under the section "Estrogen, and other hormones and factors receptor status" within Chapter 21 — Factors influencing health status and contact with health services (Z00-Z99). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where Z17.32 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, Z17.32 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Z17.32 is the ICD-10-CM diagnosis code for "Human epidermal growth factor receptor 2 negative status". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of Z17.32 is Z17.3 ("Human epidermal growth factor 2 receptor"). Z17.32 provides a more specific classification within this category.
Z17.32 is located in Section Z17 — "Estrogen, and other hormones and factors receptor status" within Chapter 21 of the ICD-10-CM Tabular List.
Use Z17.32 when the patients documented diagnosis matches "Human epidermal growth factor receptor 2 negative status" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Human epidermal growth factor receptor 2 negative status is Z17.32.
Yes, Z17.32 can be used as a primary diagnosis code since it is billable and specific.
Z17.32 is in Chapter 21 of the ICD-10-CM Tabular List.
Yes, Z17.32 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.